Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | COMT | P21964 | 8/20 | 0.49 |
| ▸ | HPGDS | O60760 | 2/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.42 |
| ▸ | SCN4A | P35499 | 1/20 | 0.42 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL863097 | 0.83 | COMT (0.41) | COMTHPGDSPIM1ALDH1A1NPC1 | |
| SCHEMBL863739 | 0.82 | IDO1 (0.47) | COMTALDH1A1NOTUM | |
| SCHEMBL11983702 | 0.80 | CCR1 (0.59) | COMTHPGDSPIM1ALDH1A1NPC1 | |
| SCHEMBL27381581 | 0.77 | NOTUM (0.59) | COMTHPGDSALDH1A1NPC1RAB9A | |
| SCHEMBL12075153 | 0.76 | SCN4A (0.52) | COMTHPGDSNPC1RAB9APOLB | |
| SCHEMBL14833561 | 0.75 | HPGDS (0.52) | COMTHPGDSALDH1A1NPC1RAB9A | |
| SCHEMBL21233176 | 0.73 | COMT (0.49) | COMTHPGDSPIM1ALDH1A1NPC1 | |
| SCHEMBL21814305 | 0.72 | CCR1 (0.56) | HPGDSPIM1 | |
| SCHEMBL29631977 | 0.72 | CCR1 (0.56) | COMTHPGDSPIM1ALDH1A1NPC1 | |
| SCHEMBL3068150 | 0.71 | SCN4A (0.62) | COMTHPGDSPIM1ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8507679-B2 | Heteroleptic, dual tridentate Ru(II) complexes as sensitizers for dye-sensitized solar cells | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-08-13 | — | — | US | disclosed |
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-03-29 | — | — | US | disclosed |
| US-20080079358-A1 | Organic electroluminescent element | FUJIFILM CORPORATION | 2008-04-03 | — | — | US | disclosed |
| US-20080079358-A1 | Organic electroluminescent element | FUJIFILM CORPORATION | 2008-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | RUVBL2, RUVBL1, CCNL2 | COMT 3371/4885HPGDS 1143/4885PIM1 4279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.